Prognostic factors in patients with non-small cell bronchogenic carcinoma and brain metastases
- 1 May 1982
- Vol. 49 (9) , 1916-1919
- https://doi.org/10.1002/1097-0142(19820501)49:9<1916::aid-cncr2820490926>3.0.co;2-8
Abstract
Prognostic factors were examined in 38 patients with nonsmall cell lung carcinoma and brain metastases. The most important factors were the response to total therapy (corticosteroids, radiotherapy, and chemotherapy) and the presence of brain metastases alone; these factors had the most impact on survival. Age, sex, histologic type of lung cancer, and initial performance status were not prognostically important. Our results indicate that certain subgroups of patients with nonsmall cell lung carcinoma and brain metastases have a favorable prognosis and should be treated aggressively.This publication has 9 references indexed in Scilit:
- Radation therapy for brain metastasesAnnals of Neurology, 1980
- Surgical treatment of single brain metastasis: Factors associated with survivalCancer, 1980
- Sequential Staging in Bronchogenic CarcinomaChest, 1979
- Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP)JAMA, 1978
- Metastatic Non-Oat-Cell Bronchogenic CarcinomaPublished by American Medical Association (AMA) ,1978
- Frequency, diagnosis, and treatment of brain metastases in 247 consecutive patients with bronchogenic carcinomaCancer, 1974
- Regression Models and Life-TablesJournal of the Royal Statistical Society Series B: Statistical Methodology, 1972
- The necropsy findings in carcinoma of the bronchusRespiratory Medicine, 1971
- A REVIEW OF EXPERIENCE WITH IRRADIATION OF BRAIN METASTASISAmerican Journal of Roentgenology, 1971